11. Dendrimer-Coated Carbohydrate Residues as Drug Delivery Trojan Horses in Glycoscience

  1. Yiyun Cheng
  1. Yoann M. Chabre and
  2. René Roy

Published Online: 14 JUN 2012

DOI: 10.1002/9781118275238.ch11

Dendrimer-Based Drug Delivery Systems: From Theory to Practice

Dendrimer-Based Drug Delivery Systems: From Theory to Practice

How to Cite

Chabre, Y. M. and Roy, R. (2012) Dendrimer-Coated Carbohydrate Residues as Drug Delivery Trojan Horses in Glycoscience, in Dendrimer-Based Drug Delivery Systems: From Theory to Practice (ed Y. Cheng), John Wiley & Sons, Inc., Hoboken, NJ, USA. doi: 10.1002/9781118275238.ch11

Editor Information

  1. School of Life Sciences, East China Normal University, P.R. China

Author Information

  1. Pharmaqam–Groupe de Recherche en Chimie Thérapeutique, Université du Québec à Montréal, Canada

Publication History

  1. Published Online: 14 JUN 2012
  2. Published Print: 15 JUN 2012

Book Series:

  1. Wiley Series in Drug Discovery and Development

Book Series Editors:

  1. Binghe Wang

ISBN Information

Print ISBN: 9780470460054

Online ISBN: 9781118275238

SEARCH

Keywords:

  • dendrimer-coated carbohydrate residues, as drug delivery Trojan horses;
  • “artificial glycoforms,” in multivalent carbohydrate–protein interactions;
  • glycodendrimers as targeting warheads, counteracting adhesion of pathogens;
  • multivalent carbosilane scaffolds, “SUPER TWIGs,” therapeutic for Shiga toxin;
  • galactosides, glycodendrimers in targeting bacterial, viral and specific tissues

Summary

This chapter contains sections titled:

  • Introduction

  • Antiinfective Multivalent Neoglycoconjugates

  • Neoglycoconjugates as Toxin Ligands

  • Conclusions

  • References